Read more
1:24 PM · 17 October 2023

Johnson & Johnson raises earnings forecasts

-
-
Open account Download free app

Johnson & Johnson (JNJ.US) today announced results for the third quarter of 2023. The company delivered strong results and significant growth progress in the third quarter, "... providing a solid foundation for future sustainable growth," - Joaquin Duato, chairman of the board and CEO of JnJ, said. 

Key details of the report:

- Third-quarter 2023 sales growth of 6.8% to $21.4 billion (estimated $21.03 billion), with operating growth of 6.4% and adjusted operating growth of 4.9%. Operating growth excluding COVID-19 vaccine of 9.0%.

- Earnings per share (EPS) of $1.69 increased 4.3%, and adjusted EPS of $2.66 (estimated $2.52) increased 19.3%.

- The company is raising its full-year forecasts for 2023 for sales and adjusted earnings per share (EPS).

Segment results:

Source: JNJ

Earnings forecasts have been raised: 

Source: JNJ

More details on the results can be found here.

The company's shares are gaining nearly 1.3% before the opening of the session.

27 March 2026, 6:24 PM

Anthropic leak and a cybersecurity sell-off

27 March 2026, 5:22 PM

Unity up 10% 🚨 A revolution at the company?

27 March 2026, 3:31 PM

US OPEN: Wall Street declines deepens

27 March 2026, 3:14 PM

US100 slumps 1.5% 🚩 Anthropic Claude pressures Nasdaq again

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits